Latest News

Page 10 of 26« First...89101112...20...Last »

April 3, 2015

Phase 2 Stem Cell Trial To Be Initiated

Posted in: Latest News, Therapies, Treatments, and Procedures

Ocata Therapeutics, Inc. (now owned by Acucela) announced on March 31, 2015 that the company has completed dosing of its Phase 1/2 studies for dry age-related macular degeneration (AMD) and Stargardt’s Macular Degeneration (SMD). A total of 38 patients have been safely dosed. The 200,000 cell cohort, the highest level planned, was successfully completed, paving
read more »

March 31, 2015

All About Eyeglasses

Posted in: Daily Living, Eye Conditions, Latest News

For something so important, most people know very little about their eyeglasses. What do those abbreviations and numbers on the prescription mean? Why do my friend and I have the same prescription numbers, when my vision is so much worse? What does 20/20 mean? If my best vision without glasses is 20/200, am I legally
read more »

March 30, 2015

Encapsulated Cell Technology Could Replace Injections in Wet AMD Patients

Posted in: Latest News

Neurotech Pharmaceuticals, Inc. announced on March 30, 2015 that the FDA has approved a Phase 2 clinical study of NT-503 Encapsulated Cell Therapy (ECT) for the treatment of wet age-related macular degeneration (AMD). ECT is an intravitreal implant that is genetically engineered to produce the biologic anti-VEGF drug NT-503 for at least 2 years. ECT, therefore, acts like
read more »

March 26, 2015

Topics in Gerontology Focuses on Vision and Aging

Posted in: Latest News

The Ohio State University Office of Geriatrics and Gerontology in collaboration with Prevent Blindness and its Ohio Affiliate, are pleased to announce the release of two new modules in the Topics in Gerontology distance education program: “Eyes Wide Open: Preventing Vision Loss” and “A Sight for Sore Eyes: Age-Related Eye Disease.” Topics in Gerontology is
read more »

March 7, 2015

An Opportunity To Be Heard

Posted in: Latest News

The 2015 White House Conference on Aging will be held in Washington, DC later this year. In preparation for the conference, the American Foundation for the Blind (AFB) is inviting people with vision loss and their caregivers to share concerns about issues that need to be addressed through state and national policy. To gather input,
read more »

February 15, 2015

What They Really Mean . . .

Posted in: Latest News

Sometimes, it’s wise to read news items in reverse. by Dan Roberts The latest magnifying technology, a switchable telescopic contact lens, has been receiving wide media attention this past week. If you read the news from the top down, and you anxiously call your eye care specialist before reading all the way to the bottom,
read more »

February 10, 2015

Notal Vision Device Shows 94% Success at Early Detection of Age-Related Macular Degeneration

Posted in: Latest News, Research and Developments

A National Eye Institute study has reported an impressive success rate at early detection of wet (neovascular) age-related macular degeneration (AMD). The study compared two groups of dry AMD patients and compared the proportion within each group for patients presenting with 20/40 acuity or better when their wet AMD was detected. An experimental group used
read more »

February 9, 2015

Legislation Re-introduced to Cover Medicare Payment for Low Vision Devices

Posted in: Latest News

Representatives Carolyn Maloney (D-N.Y.) and Gus Bilirakis (R-Fla.) have re-introduced H.R. 3749, the Medicare Demonstration of Coverage for Low Vision Devices Act. This bill, now called H.R. 729, is intended to provide data that would assist the new Congress in making changes to the current Medicare program, which does not pay for magnifiers needed by low
read more »

February 9, 2015

February is Macular Degeneration/Low Vision Awareness Month

Posted in: Latest News

Prevent Blindness, the nation’s oldest volunteer eye health and safety organization, has declared February as Age-related Macular Degeneration/Low Vision Awareness Month. The primary goal is to educate not only about AMD and low vision, but also to make the public aware of the free services the group provides. The group hosts a dedicated website, “The AMD
read more »

February 7, 2015

FDA approves Lucentis to treat diabetic retinopathy in patients with diabetic macular edema

Posted in: Latest News, Therapies, Treatments, and Procedures

The U.S. Food and Drug Administration announced today that they have expanded the approved use for Lucentis 0.3 mg (Genentech) to treat diabetic retinopathy in patients with diabetic macular edema. The FDA previously had approved Lucentis to treat DME and macular edema secondary to retinal vein occlusions, both of which cause fluid to leak into
read more »

Page 10 of 26« First...89101112...20...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann